Trial intelligence / Profile preview

Effects of Atorvastatin on Sperm Quality in Healthy Men

NCT02094313Phase 1Completed

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Jan 2008
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of atorvastatin in hypercholesterolemia, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoints: Modifications on semen quality at 5 months and Modifications on semen quality after withdrawal at 8 months. Started Jan 2008; status: completed.

02

Drugs

atorvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT02094313.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02094313.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call